As of
June 30, 2024

As of
December 31, 2023

(in thousands)

Product revenue related reserves

$

104,652

$

100,075

Accrued contract manufacturing costs

77,451

33,024

Accrued employee compensation costs

50,023

78,732

Accrued clinical and pre-clinical costs

36,221

34,669

Accrued professional fees

22,885

17,187

Accrued fixed assets

21,163

3,231

Accrued income taxes

18,186

13,766

Accrued royalties

7,724

12,070

Accrued interest

4,368

4,395

Accrued research expenses

2,737

2,441

Other

4,994

4,032

Total accrued expenses

$

350,404

$

314,997